Critical role of chemokine CXCL10 (IP-10) in non-viral and viral ARDS

被引：0
|
作者：
Ohto-Nakanishi, Takayo [1 ]
Fiala, Roderik [1 ]
Penninger, Josef [2 ]
Slutsky, Arthur [3 ]
Kuba, Keiji [1 ]
Imai, Yumiko [1 ]
机构：
[1] Akita Univ, Grad Sch Med, Dept Biol Informat & Exp Therapeut, Akita 0108543, Japan
[2] IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria
[3] St Michaels Hosp, Dept Crit Care, Toronto, ON M5B 1W8, Canada
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：106P / 106P
页数：1
相关论文
共 50 条
  • [1] Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10
    Tager, AM
    Kradin, RL
    LaCamera, P
    Bercury, SD
    Campanella, GSV
    Leary, CP
    Polosukhin, V
    Zhao, LH
    Sakamoto, H
    Blackwell, TS
    Luster, AD
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2004, 31 (04) : 395 - 404
  • [2] Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine
    Swaminathan, GJ
    Holloway, DE
    Colvin, RA
    Campanella, GK
    Papageorgiou, AC
    Luster, AD
    Acharya, KR
    STRUCTURE, 2003, 11 (05) : 521 - 532
  • [3] CXCL10 Chemokine: A Critical Player in RNA and DNA Viral Infections
    Elemam, Noha Mousaad
    Talaat, Iman Mamdouh
    Maghazachi, Azzam A.
    VIRUSES-BASEL, 2022, 14 (11):
  • [4] CXCR3 and heparin binding sites of the chemokine IP-10 (CXCL10)
    Campanella, GSV
    Lee, EMJ
    Sun, J
    Luster, AD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (19) : 17066 - 17074
  • [5] IP-10 (CXCL10) release following viral sensing by pulmonary artery cells-role of Toll like receptors
    Badiger, R.
    Mitchell, J.
    Paul-Clark, M.
    Wort, S.
    De Sousa, P.
    Johnson, S.
    Edwards, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 38 - 39
  • [6] The CXCR3 binding chemokine IP-10/CXCL10: Structure and receptor interactions
    Booth, V
    Keizer, DW
    Kamphuis, MB
    Clark-Lewis, I
    Sykes, BD
    BIOCHEMISTRY, 2002, 41 (33) : 10418 - 10425
  • [7] CXCL10/IP-10 Is a Biomarker and Mediator for Kawasaki Disease
    Ko, Tai-Ming
    Kuo, Ho-Chang
    Chang, Jeng-Sheng
    Chen, Shih-Ping
    Liu, Yi-Min
    Chen, Hui-Wen
    Tsai, Fuu-Jen
    Lee, Yi-Ching
    Chen, Chien-Hsiun
    Wu, Jer-Yuarn
    Chen, Yuan-Tsong
    CIRCULATION RESEARCH, 2015, 116 (05) : 876 - 883
  • [8] An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
    Yates-Binder, Cecelia C.
    Rodgers, Margaret
    Jaynes, Jesse
    Wells, Alan
    Bodnar, Richard J.
    Turner, Timothy
    PLOS ONE, 2012, 7 (07):
  • [9] Chemokine CXCL10 (IP-10) is sufficient to trigger an immune response to injected antigens in a mouse model
    Krathwohl, MD
    Anderson, JL
    VACCINE, 2006, 24 (15) : 2987 - 2993
  • [10] Maternal serum concentrations of the chemokine CXCL10/IP-10 are elevated in acute pyelonephritis during pregnancy
    Gotsch, Francesca
    Romero, Roberto
    Espinoza, Jimmy
    Kusanovic, Juan Pedro
    Mazaki-Tovi, Shali
    Erez, Offer
    Than, Nandor Gabor
    Edwin, Samuel
    Mazor, Moshe
    Yoon, Bo Hyan
    Hassan, Sonia S.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2007, 20 (10): : 735 - 744
12345